Projects Represent Approximately 2500% Year over Year Growth in New Contract Value

MORRISVILLE, N.C. (Business Wire) October 12, 2010 — Clinipace Worldwide, a global digital clinical research organization (dCRO), announced today that the company has been awarded twelve new projects since June, representing approximately 2500% growth in new contract value over the same period in 2009. These projects range from functional services such as data management, clinical operations, and regulatory consulting to running all aspects of Phase 1 through Phase 3 clinical trials.

These twelve projects were awarded from ten different clients, seven of which are new to the Clinipace Worldwide portfolio; and include multiple therapeutic areas such as oncology, immunology, nephrology, endocrinology and respiratory.

“We’re hearing the same pain point over and over again when engaging with new global clients – the need for more efficient, optimized trials with better data and trial visibility,” said Jeff Williams, CEO, Clinipace Worldwide. “The explosive growth of our global customer base is a testament to our proven technology-amplified service delivery model to clinical trial management. Building service solutions on top of a technology platform is the most powerful and cost-effective way to enhance the success of a clinical trial or related project. The industry more commonly does just the opposite, layering technology on top of the service layer and this is inefficient.”

About Clinipace Worldwide

Clinipace Worldwide, a global digital clinical research organization (dCRO), specializes in fully-integrated clinical research services for biopharmaceutical and medical device firms. Optimized by TEMPO™, its proprietary eClinical platform, the Clinipace team of experts brings extensive knowledge and insight into site selection, patient recruitment, clinical operations, data management, medical monitoring, biostatistics, and regulatory affairs to ensure a successful clinical development program through proactive clinical trial management. With specific expertise in oncology, among other therapeutic areas, Clinipace Worldwide has managed over 90 contract research projects conducted at almost 3,000 sites with 100,000 patients. Clinipace Worldwide is headquartered in Research Triangle Park, NC with additional domestic operations in Overland Park, KS, and South American operations based in Brazil, Argentina, and Peru. For more information visit our website at